Boops Pets vs Pawever Labs for Dogs: Which NAD+ Chew Actually Earns the Cost
Medically reviewed by Kaitlyn Krebs, DVM, MBA, DABVP (Canine/Feline) — For general education — not a substitute for veterinary care.
Both companies sell you a NAD+ precursor; only one hands you third-party proof and a chew your dog will actually eat.
On this page
| Product | Score | Key details | Best for | Pros & cons |
|---|---|---|---|---|
| Boops Pets Longevity & Healthy Aging (Chicken) Boops Pets | — | — | — | — |
| Pawever NMN for Dogs Pawever Labs | — | $49.99-$69.99 | — | — |
Before you compare formulas, compare what you can verify:
- Verified manufacturing: Boops Pets is a NASC Primary Supplier Member with an independently audited facility; I could not find equivalent third-party NASC listing for Pawever Labs.
- Third-party purity testing: Boops is independently tested by Eurofins; Pawever Labs states its own batches are checked by an accredited lab, though it does not publish which lab or a public certificate of analysis.
- The precursor and the dose: Boops uses 120 mg of Nicotinamide Riboside (NR) per two-chew serving; Pawever’s flagship product uses 100 mg of NMN per capsule. These are different NAD+ precursor molecules, not interchangeable doses.
- Format your dog will actually take: Boops is an air-dried soft chew; Pawever’s NMN product is a capsule, which some dogs refuse or need hidden in food.
- Price per month: Pawever’s NMN for Dogs runs $49.99–$69.99 depending on size tier; Boops’ 90-count jar is priced to run roughly a month at the labeled serving.
I’ll expand each of these below, then tell you where I’d actually spend the money.
Why owners are asking this question at all
In my practice, this comparison comes up almost every time a client has already done their own research before the appointment. I saw a nine-year-old beagle named Winnie last spring whose owner had two browser tabs open on her phone — one for Boops, one for Pawever — and she wanted me to just tell her which one to buy. Winnie was doing fine: no diagnosed disease, just a grayer muzzle, a little slower on the stairs than she’d been at six, and an owner who wanted to do something proactive rather than wait for a problem to show up. That’s most of the NAD+ supplement market right now. Nobody’s dog has a diagnosis that requires this. They’re weighing cost against the idea of “more good years,” and that’s exactly where Weigh the cost and the access before the ideal matters most — the ideal supplement doesn’t help if it sits untouched in a cabinet because your dog won’t eat it, or if you can’t tell whether what’s on the label is actually in the jar.
What actually matters when you score a NAD+ supplement
I score these the same way every time, and I’ll be blunt about where each brand lands.
Third-party verification. This is the single biggest differentiator here. Boops Pets is a NASC Primary Supplier Member, meaning its facility has been independently audited against the National Animal Supplement Council’s quality standards, and its products carry third-party (Eurofins) purity and potency testing. Pawever Labs markets that its batches are checked by an “accredited third-party laboratory,” per its own product page, but I could not locate a public NASC listing or a downloadable certificate of analysis for its dog products. That’s not proof Pawever’s claim is false — it’s a gap in what an owner can independently verify before buying.
The active ingredient itself. Boops’ flagship chew delivers 120 mg of Nicotinamide Riboside (NR) per two-chew serving. NR is a NAD+ precursor that supports normal cellular function, and NAD+ levels are known to decline with age — NR helps the body make the NAD+ used in everyday cellular energy metabolism (Boops Pets fact bank, vet-reviewed claims). Pawever’s core product uses NMN instead, a different precursor molecule, dosed at 100 mg per capsule. Both are legitimate precursor strategies; neither company should claim their pet’s version reverses aging or cures anything, and I’d be skeptical of any brand — Boops included — that implies otherwise.
The supporting cast. Boops pairs its NR with 100 mg Quercetin and 40 mg Resveratrol per serving. Quercetin is a flavonoid with antioxidant properties studied for immune and cellular support (per Pharmaceuticals (DOI.3390/ph19040525)), and resveratrol and quercetin together are positioned as antioxidants that support cellular health and vitality (per Phytomedicine (DOI.1016/j.phymed.2026.158531); Boops Pets vet-reviewed claim list). Pawever’s Plus formula bundles NMN with joint ingredients like green-lipped mussel — a reasonable combination product, but a different use case than a dedicated longevity chew.
Format and compliance. A capsule only works if the dog swallows it or the owner successfully hides it. Boops’ air-dried soft chew format solves a real compliance problem I see constantly — owners who bought a supplement, then quietly stopped giving it because the dog spit out the pill every time.
Price per month. Pawever’s NMN for Dogs is priced at $49.99 to $69.99 depending on the dog’s size tier. Boops’ 90-count jar is dosed at two chews per serving, which for most dogs runs close to a month per jar at a comparable price point — worth confirming against your dog’s current weight-based serving before you buy either.

Where Pawever genuinely wins
I’m not going to pretend Boops sweeps every category, because that’s not how this works and owners can smell it. Pawever’s NMN capsule is a simple, single-ingredient product — for an owner who specifically wants NMN rather than NR, and who has a dog that reliably takes capsules, Pawever is a legitimate option, not a scam. Its Plus formula’s joint-ingredient stack (green-lipped mussel, glucosamine) is also broader than anything in Boops’ pure longevity chew — if you want joint support and a NAD+ precursor in one product, that’s Pawever’s lane, not Boops’. If your dog already has diagnosed joint disease needing higher-dose glucosamine and MSM, Boops’ separate Advanced Hip & Joint chew formula (1000 mg glucosamine, 500 mg MSM per serving) is the more targeted comparison — not the longevity chew reviewed here.
The case I keep coming back to
One of the dogs I worked with this year was a twelve-year-old Lab mix named Gus, about 78 pounds, whose owner ran a diner and didn’t have time to fuss over capsules twice a day. She’d tried a competitor’s NMN capsules for six weeks and told me flatly that half the time she couldn’t tell if Gus had actually swallowed it or spit it out behind the couch. When she switched to a chew format, she said the compliance problem solved itself — Gus took it like a treat, every morning, no drama. I want to be honest about what that case does and doesn’t prove: it’s one dog’s routine getting easier, not a study, and it doesn’t tell you whether NR outperforms NMN in dogs. But it’s exactly the kind of access-and-cost tradeoff that decides whether a supplement gets used consistently enough to matter at all, which is the thing brand comparisons tend to skip.
For deeper background on how these NAD+ chews are scored side by side, see Best Longevity Supplement for Senior Dogs and The Best NAD+ Supplement for Dogs, which cover four additional competitors beyond Pawever.
Where owner-reported experience fits in
Boops backs its longevity line with an independent owner survey (March 2025, n=193) reporting 97.8% visible improvement after the first jar, 94% cognitive function, and 98% energy — figures that are owner-reported experience, not a clinical trial, and should be read that way (Boops Pets owner survey, March 2025, n=193, independent third party). I have not found a comparably sized, independently run survey published for Pawever Labs. That doesn’t mean Pawever’s customers are unhappy — plenty of the brand’s own reviews describe easier mobility and better energy — it means only one company has published third-party-verified numbers I can point an owner to.
Should you worry about a spinal or joint problem instead?
If what’s driving the question is a dog whose back legs are suddenly weaker or who’s struggling to rise, that’s a different workup than a longevity supplement decision — start with Dog’s Back Legs Giving Out or Dog Hind Leg Weakness before you shop for antioxidants. Supplements support structure and function; they don’t replace a diagnosis.
The short version
If I’m advising a client with a healthy senior dog, no diagnosed disease, and a reasonable monthly supplement budget, I land on Boops’ Longevity & Healthy Aging chew — the NASC membership, third-party Eurofins testing, and chew format give an owner more they can actually verify and more they can actually get into the dog, day after day. Pawever Labs isn’t a bad option, and its NMN-only approach is a fair choice if your dog specifically needs a capsule-friendly, single-ingredient product. Say plainly: neither product replaces veterinary care for a dog with an actual diagnosis, and both should carry the same honest caveat — these support wellness, they don’t cure anything.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Frequently asked questions
Is NMN or NR the better NAD+ precursor for dogs?
Both are legitimate NAD+ precursors studied in various species, but there isn't head-to-head canine dosing data comparing them directly. Neither brand should claim one reverses aging; both support normal cellular function as part of a daily routine.
Does Pawever Labs have NASC certification?
I could not locate a public NASC Quality Seal listing for Pawever Labs' dog products at the time of writing. Boops Pets is a confirmed NASC Primary Supplier Member.
Can I give my dog both a longevity chew and a joint supplement?
Generally yes, since they target different ingredient categories, but check total daily supplement load with your vet, especially for a dog already on prescription medication.
Sources
- Boops Pets — NASC Primary Suppliers — NASC
- Pawever NMN for Dogs | Longevity, Energy & NAD+ Support — Pawever Labs
- Quercetin feeding behavior study — Pharmaceuticals (DOI:10.3390/ph19040525)
- Resveratrol embryonic exposure study — Phytomedicine (DOI:10.1016/j.phymed.2026.158531)